Genome-wide replacement by DS-1-like equine-like G3P[8] rotaviruses in Taiwan and implications for vaccine effectiveness
Abstract
Rotavirus vaccines reduce severe gastroenteritis, but reassortment and the emergence of animal-like strains raise concerns about vaccine mismatch. We analyzed hospital-based surveillance in Taiwan during 2005–2017, integrating VP7/VP4 genotyping, whole-genome sequencing (WGS), and a test-negative vaccine-effectiveness study during 2014–2017. Rotavirus positivity among hospitalized children with acute gastroenteritis declined from 25.6% in 2005–2007 to 18.4% in 2008–2011 and 10.3% in 2014–2017, while the detection of G3P[8] strains increased in the late-vaccine period. By 2014, equine-like VP7 G3P[8] viruses had largely replaced previously circulating typical human Wa-like G3P[8] strains; 271/276 G3P[8] detections were equine-like. Whole-genome sequencing of a subset yielded 132 near-complete genomes overall, including 61 G3P[8] genomes; all G3P[8] genomes sequenced from 2005 to 2011 were Wa-like, whereas 37 of 40 sequenced post-2014 G3P[8] genomes had DS-1-like backbones. In the 2014–2017 test-negative vaccine-effectiveness analysis, unconditional logistic regression controlling for age in months, hospital site, calendar year, and calendar month showed high protection against rotavirus-associated hospitalization for Rotarix (82.0%, 95% CI 75.9–86.6) and RotaTeq (90.1%, 95% CI 83.5–94.0). Vaccine effectiveness estimates restricted to WGS-confirmed G3P[8] DS-1-like cases were imprecise and exploratory. These data provide indirect epidemiologic evidence that protection against severe rotavirus hospitalization was maintained during the emergence of the dominant equine-like DS-1-like G3P[8] lineage.
Related
- Effectiveness of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine in Children Aged 6 Months–6 Years During a Statewide Pertussis Outbreak — Alaska, May–November 2024
- Cost-effectiveness of 13-valent pneumococcal vaccine for children under 5 years of age at high altitude in China : A modeling analysis
- Trust in HPV vaccine effectiveness and safety and willingness to initiate HPV vaccination among unvaccinated female college students recruited through university-based online networks in China: a cross-sectional study
- An LLM enabled real-time estimation of seasonal influenza vaccine effectiveness from social media data
- Separating the effects of immune waning and viral evolution on COVID-19 vaccine effectiveness reveals improved effectiveness of updated vaccines
BibTeX
@article{velasquezportocarrero2026genomewide,
title = {{Genome-wide replacement by DS-1-like equine-like G3P[8] rotaviruses in Taiwan and implications for vaccine effectiveness}},
author = {Daniel E. Velasquez-Portocarrero and Kun-Lin Tsai and Ching-Yi Wu and Jacqueline Tate and Baoming Jiang and Fang-Tzy Wu},
journal = {Scientific Reports},
year = {2026},
month = sep,
doi = {10.1038/s41598-026-73101-w},
url = {https://www.nature.com/articles/s41598-026-73101-w},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genome-wide replacement by DS-1-like equine-like G3P[8] rotaviruses in Taiwan and implications for vaccine effectiveness
AU - Daniel E. Velasquez-Portocarrero
AU - Kun-Lin Tsai
AU - Ching-Yi Wu
AU - Jacqueline Tate
AU - Baoming Jiang
AU - Fang-Tzy Wu
PY - 2026
DA - 2026/09/30
JO - Scientific Reports
DO - 10.1038/s41598-026-73101-w
UR - https://www.nature.com/articles/s41598-026-73101-w
AB - Rotavirus vaccines reduce severe gastroenteritis, but reassortment and the emergence of animal-like strains raise concerns about vaccine mismatch. We analyzed hospital-based surveillance in Taiwan during 2005–2017, integrating VP7/VP4 genotyping, whole-genome sequencing (WGS), and a test-negative vaccine-effectiveness study during 2014–2017. Rotavirus positivity among hospitalized children with acute gastroenteritis declined from 25.6% in 2005–2007 to 18.4% in 2008–2011 and 10.3% in 2014–2017, while the detection of G3P[8] strains increased in the late-vaccine period. By 2014, equine-like VP7 G3P[8] viruses had largely replaced previously circulating typical human Wa-like G3P[8] strains; 271/276 G3P[8] detections were equine-like. Whole-genome sequencing of a subset yielded 132 near-complete genomes overall, including 61 G3P[8] genomes; all G3P[8] genomes sequenced from 2005 to 2011 were Wa-like, whereas 37 of 40 sequenced post-2014 G3P[8] genomes had DS-1-like backbones. In the 2014–2017 test-negative vaccine-effectiveness analysis, unconditional logistic regression controlling for age in months, hospital site, calendar year, and calendar month showed high protection against rotavirus-associated hospitalization for Rotarix (82.0%, 95% CI 75.9–86.6) and RotaTeq (90.1%, 95% CI 83.5–94.0). Vaccine effectiveness estimates restricted to WGS-confirmed G3P[8] DS-1-like cases were imprecise and exploratory. These data provide indirect epidemiologic evidence that protection against severe rotavirus hospitalization was maintained during the emergence of the dominant equine-like DS-1-like G3P[8] lineage.
SN - 2045-2322
ER -